142 related articles for article (PubMed ID: 6161604)
21. Persistence of the viral genome in interferon-treated cells infected with oncogneic or nononcogenic viruses.
Friedman RM; Costa JC; Ramseur JM; Meyers MW; Jay FT; Chang EH
J Infect Dis; 1976 Jun; 133 Suppl():A43-50. PubMed ID: 180209
[TBL] [Abstract][Full Text] [Related]
22. Radiometric detection of herpes simplex viruses.
D'Antonio NL; Tsan MF; Griffin DE; Charache PA; Wagner HN
J Nucl Med; 1978 Feb; 19(2):185-90. PubMed ID: 203666
[TBL] [Abstract][Full Text] [Related]
23. Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses.
Ahmed M; Cramer SD; Lyles DS
Virology; 2004 Dec; 330(1):34-49. PubMed ID: 15527832
[TBL] [Abstract][Full Text] [Related]
24. Antiviral effect of two aryl-oligopeptides, FR41565 and FR48217.
Oku T; Imanishi J; Kishida T
Antiviral Res; 1986 Jul; 6(4):233-9. PubMed ID: 2427022
[TBL] [Abstract][Full Text] [Related]
25. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
26. Biosynthesis of mouse interferon by translation of its messenger RNA in a cell-free system.
Thang MN; Thang DC; De Maeyer E; Montagnier L
Proc Natl Acad Sci U S A; 1975 Oct; 72(10):3975-7. PubMed ID: 172890
[TBL] [Abstract][Full Text] [Related]
27. Study of the antiviral activity of some new classes of AS-triazine derivatives (preliminary note).
Tomas E; Popescu A; Zuivertz A; Jucu V; Czabor F; Cristescu C
Rom J Virol; 1995; 46(1-2):51-6. PubMed ID: 9106401
[TBL] [Abstract][Full Text] [Related]
28. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
29. Sensitivity of herpes simplex virus types 1 and 2 to three preparations of human interferon.
Overall JC; Yeh TJ; Kern ER
J Infect Dis; 1980 Dec; 142(6):943. PubMed ID: 6161973
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Herpes simplex virus infections with topical antiviral agents.
Hamuy R; Berman B
Eur J Dermatol; 1998; 8(5):310-9. PubMed ID: 9683881
[TBL] [Abstract][Full Text] [Related]
31. Selective in vitro and in vivo activities of 5-(2-haloalkyl)pyrimidine nucleoside analogs, particularly 5-(2-chloroethyl)-2'-deoxyuridine, against herpes simplex virus.
De Clercq E; Rosenwirth B
Antimicrob Agents Chemother; 1985 Aug; 28(2):246-51. PubMed ID: 3010841
[TBL] [Abstract][Full Text] [Related]
32. Relative sensitivities of viruses to different species of interferon.
Stewart WE; Scott WD; Sulkin SE
J Virol; 1969 Aug; 4(2):147-53. PubMed ID: 4308914
[TBL] [Abstract][Full Text] [Related]
33. [Combined activity of meliacin and foscarnet against different strains of herpes simplex virus type 1 using a three-dimensional model].
Barquero AA; Villamil SM
Rev Argent Microbiol; 1997; 29(1):32-7. PubMed ID: 9229723
[TBL] [Abstract][Full Text] [Related]
34. Cell surface alterations induced by the acycloguanosine (ACG) resistant and sensitive strains of herpes simplex virus type 2 (HSV-2) in the presence of ACG and tunicamycin.
Gamliel H; Katz E
Scan Electron Microsc; 1983; (Pt 4):2037-45. PubMed ID: 6322282
[TBL] [Abstract][Full Text] [Related]
35. [Antiviral sensitivity of herpes simplex virus in immunocompromised patients].
Illán H; Jacob N; Maiolo E; Cisterna D; Schiavelli R; Freire MC
Rev Argent Microbiol; 2004; 36(2):88-91. PubMed ID: 15470869
[TBL] [Abstract][Full Text] [Related]
36. Role of Us3 gene of herpes simplex virus type 1 for resistance to interferon.
Piroozmand A; Koyama AH; Shimada Y; Fujita M; Arakawa T; Adachi A
Int J Mol Med; 2004 Oct; 14(4):641-5. PubMed ID: 15375595
[TBL] [Abstract][Full Text] [Related]
37. Antiviral activity of interferon in rats and the effect of immune suppression.
Schellekens H; Smiers-de Vreede E; de Reus A; Dijkema R
J Gen Virol; 1984 Feb; 65 ( Pt 2)():391-6. PubMed ID: 6198453
[TBL] [Abstract][Full Text] [Related]
38. [Sensitivity of herpes simplex virus to 5-iodo-2'-deoxyuridine].
Cocchi P
G Mal Infett Parassit; 1965 Dec; 17(12):874-6. PubMed ID: 4286637
[No Abstract] [Full Text] [Related]
39. Synergy of 9-beta-D-arabinofuranosyladenine and human interferon against Herpes simplex virus, type 1.
Lerner AM; Bailey EJ
J Infect Dis; 1974 Nov; 130(5):549-52. PubMed ID: 4371532
[No Abstract] [Full Text] [Related]
40. Concentrations of idoxuridine in serum, urine, and cerebrospinal fluid of patients with suspected diagnoses of Herpesvirus hominis encephalitis.
Lerner AM; Bailey EJ
J Clin Invest; 1972 Jan; 51(1):45-9. PubMed ID: 4331799
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
